Boardroom Alpha
Boardroom Alpha
SOLV · Additional Proxy Materials (DEFA14A) · Filed March 27, 2026

Solventum Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 27, 2026
Ticker
SOLV
Accession
0001964738-26-000018
Boardroom Alpha · Filing insights

Solventum's board urges a vote FOR all four director nominees, the executive compensation advisory proposal, and PwC’s ratification.

About Solventum Corp
Market cap
$13.2B
1Y TSR
−0.4%
Board grade
C+
Sector
Healthcare
CEO
Bryan C Hanson
Last annual meeting: May 15, 2026 · View full Solventum Corp profile →
solventumcorporation_vxc
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☑ Definitive Additional Materials ☐ Soliciting Material under §240.14a-12 SOLVENTUM CORPORATION (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): ☑ No fee required ☐ Fees paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11


 
Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V87369-P40173 SOLVENTUM CORPORATION 1750 YANKEE DOODLE ROAD EAGAN, MN 55121 SOLVENTUM CORPORATION You invested in SOLVENTUM CORPORATION and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 15, 2026. Vote Virtually at the Meeting* May 15, 2026 9:00 AM EDT Virtually at: www.virtualshareholdermeeting.com/SOLV2026 *Please check the meeting materials for any special requirements for meeting attendance. Get informed before you vote View the Notice and Proxy Statement, Annual Report and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 1, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. 2026 Annual Meeting Vote by May 14, 2026 11:59 PM ET. For shares held in a Plan, vote by May 12, 2026 11:59 PM ET.


 
Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V87370-P40173 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of Directors Nominees: 1a. Carlos Albán For 1b. Susan D. DeVore For 1c. Shirley Edwards For 1d. Dr. Bernard A. Harris Jr. For 2. Advisory vote to approve executive compensation For 3. Ratification of the appointment of PwC as Solventum’s independent registered public accounting firm for the fiscal year ending December 31, 2026 For NOTE: Such other business as may properly come before the meeting or any adjournment thereof.


 
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Solventum Corp (SOLV)

Reference

Frequently asked questions

When did Solventum Corp file this DEFA14A?
Solventum Corp (SOLV) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 27, 2026. The accession number assigned by EDGAR is 0001964738-26-000018.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Solventum's board urges a vote FOR all four director nominees, the executive compensation advisory proposal, and PwC’s ratification. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Solventum Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Solventum Corp has filed under CIK 1964738, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer